Brief: CyTOF And Maxpar Direct Technologies Used In Study On Pregnant Women With SARS-CoV-2

Standard BioTools

31/08/2021 13:42

Aug 31 (Reuters) - Fluidigm Corp  FLDM.O :
    * CYTOF AND MAXPAR DIRECT TECHNOLOGIES UTILIZED IN STUDY
CHARACTERIZING IMMUNE AND INFLAMMATORY RESPONSES IN PREGNANT
WOMEN INFECTED WITH SARS-COV-2

Source text for Eikon:  ID:nGNXbtqwG1 
Further company coverage:  FLDM.O 

 ((Reuters.Briefs@thomsonreuters.com;))